The Thomas Alber Memorial Fund in Infectious Diseases
The Alber Family and Berkeley faculty together have set a goal of raising $50,000 to name an ongoing lecture series in honor of Tom Alber, founding faculty director of CEND. We hope that you will join us in celebrating his legacy and that you will consider making a gift to help establish a lecture series
- Published in news
Diagnostics and Global Health Experts Meet at Diagnostics by Design Workshop
On January 9, 2014, the PoCDx IdeaLab, Tekla Labs, and the Henry Wheeler Center for Emerging & Neglected Diseases (CEND) hosted a workshop on the design, development, and implementation of global health technologies. The event attracted over 100 attendees from academia, industry, and the non-profit sector. Videos from the keynote speakers and panel discussion are available
Diagnostics by Design: A Hack Day for Global Health
On January 11 and 12th, 2014, the Henry Wheeler Center for Emerging and Neglected Diseases (CEND), Tekla Labs, and the Invention Lab @ CITRIS hosted a unique hack-a-thon on the UC Berkeley campus, “Diagnostics by Design: a hack day for global health.” The Diagnostics by Design hackathon was designed as a cross-communities effort to bridge
TB Diagnostics Resources Available via Cal Alum
Dr. Madhukar Pai, MD, PhD, of McGill University has compiled a list of resources for diagnostics developers working in the tuberculosis field: UNITAID TB Dx technology and market landscape. 2013 semi-annual update. http://www.unitaid.org/images/marketdynamics/publications/UNITAID-TB_Dx_Landscape-Update_Dec%202013.pdf Robust, reliable and resilient: designing molecular tuberculosis tests for microscopy centers in developing countries. http://www.expert-reviews.com/doi/full/10.1586/14737159.2013.850034 Are peripheral microscopy centres ready for next generation molecular tuberculosis
- Published in news
UC Berkeley Discovery Leads to Malaria Drug
Twelve years after a breakthrough at UC Berkeley, a discovery from the laboratory of Dr. Jay Keasling will finally be reaching those in need. On April 11, 2013, Sanofi launched production of semi-synthetic artemisinin, a key ingredient in the current gold standard for malaria treatment. Read the full story at the UC Berkeley News Center.
Understanding Health Disparities at Home and Abroad
The UC Berkeley Minority Health/Global Health (MH/GH) Training Program aims to provide international research experience and training in the health sciences and public health for undergraduate and graduate students committed to reducing U.S. and international health disparities. The program is largely built on the philosophy that providing underrepresented students with the opportunity to bring knowledge